- Furaltadone hydrochloride
-
- $1.00 / 1KG
-
2025-11-11
- CAS:3759-92-0
- Min. Order: 1KG
- Purity: 98.0 ～ 102.0%
- Supply Ability: 1ton/month
- Furaltadone hydrochloride
-
- $8.00 / 1KG
-
2025-09-25
- CAS:3759-92-0
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: g-kg-tons, free sample is available
|
| | Furaltadone hydrochloride Basic information |
| | Furaltadone hydrochloride Chemical Properties |
| Melting point | >300?C (dec.) | | storage temp. | Keep in dark place,Inert atmosphere,2-8°C | | solubility | DMSO (Slightly), Methanol (Slightly) | | form | Solid | | color | Light Yellow to Yellow | | Stability: | Hygroscopic | | CAS DataBase Reference | 3759-92-0(CAS DataBase Reference) |
| Hazard Codes | Xn | | Risk Statements | 22 | | RIDADR | 3249 | | WGK Germany | 3 | | RTECS | RQ3630000 | | HazardClass | 6.1(b) | | PackingGroup | III |
| | Furaltadone hydrochloride Usage And Synthesis |
| Chemical Properties | Yellow Solid | | Uses | Antibacterial;Bacterial DNA damage | | Uses | A metabolite of Nitrofuran in milk. Antibacterial. | | Uses | Furaltadone Hydrochloride is an antibacterial compound.Environmental contaminants; Food contaminants; Heat processing contaminants | | in vivo | Furaltadone (3-30 mg/kg, p.o., single dose) reduces the allergic response in IgE-mediated PCA in BALB/c mice by inhibiting mast cell activation and degranulation[3]. | Animal Model: | IgE-mediated passive cutaneous anaphylaxis (PCA) in BALB/c mice[3] | | Dosage: | 3、10、30 mg/kg | | Administration: | Oral gavage (p.o.), single dose | | Result: | Significantly inhibited the allergic response in a dose-dependent manner and reduced mast cell degranulation in the skin. |
|
| | Furaltadone hydrochloride Preparation Products And Raw materials |
|